Brooke Worster, MD

Enterprise Director, Supportive Oncology
Medical Director, MS in Medical Cannabis Science & Business, IEHP
Associate Professor

Brooke Worster, MD

Contact

Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107

Email Brooke Worster

215-955-8874

Brooke Worster, MD

Enterprise Director, Supportive Oncology
Medical Director, MS in Medical Cannabis Science & Business, IEHP
Associate Professor

Education

Medical School

Temple University School of Medicine, Philadelphia, PA - 2007

Residency

Internal Medicine, Temple Hospital, Philadelphia, PA - 2010

Fellowship

Palliative Care Massachusetts General Hospital & DFCI Boston, MA - 2012
Pain, MGH &  Dana Farber Cancer Institute, Boston, MA - 2013

Publications

Certifications

  • SAMHSA X Waiver - 2019

Awards

  • Attending Teaching Award, Thomas Jefferson University Hospital - 2015
  • Gold Humanism Honor Society, Sidney Kimmel Medical College - 2018
  • Leadership Academy, Jefferson Health - 2018
  • Dean’s Award for Excellence in Education, Sidney Kimmel Medical College - 2018
  • James B. Erdmann, PhD Award for Excellence In Interprofessional Collaborative Practice - 2018

Research & Clinical Interests

My research interests focus on improving the quality of life for patients with serious illness – both the impact, risks and benefits of cannabis compared to other prescription pharmacotherapy for pain and other burdensome symptoms as well as how to quantify and maximize the benefits of team-based interprofessional interactions for patients and their families. 

Biography

Dr. Worster grew up in central Pennsylvania, attended medical school in Philadelphia at Temple University, completed her internal medicine residency and was a chief resident after completing her residency at Temple as well. This is where she fell in love with treating underserved patients with serious illness. Subsequently she completed a pain and palliative medicine fellowship in Boston, MA at the Harvard MGH/Dana Farber Palliative Care/Pain program and loves the challenges of creating a Supportive Medicine and Cancer Survivorship Program spanning the Sidney Kimmel Comprehensive Cancer Center enterprise, as well as new endeavors in transitional, home base and nursing home palliative care.